|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51626681
線上人數 :
919
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"liao ch"的相關文件
顯示項目 111-120 / 132 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2005-07 |
Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
|
Liao, CH; Cheng, JT; Teng, CM. |
| 中國醫藥大學 |
2005-04-28 |
Disabled-2 is a negative regulator of integrin aIIbb3-mediated fibrinogen adhesion and cell signaling
|
(Tseng CP); (Huang CL); 鄭如茜(Ju Chien Cheng); (Liao CH) |
| 中國醫藥大學 |
2005-04-28 |
Disabled-2 is a negative regulator of integrin aIIbb3-mediated fibrinogen adhesion and cell signaling
|
(Tseng CP); (Huang CL); 鄭如茜(Ju Chien Cheng); (Liao CH) |
| 國立臺灣大學 |
2005-02 |
Clipless needlescopic bilateral varix ligation
|
Chueh, SC; Liao, CH; Wang, SM; Hsieh, MH; Lai, MK; Jun, C |
| 國立屏東大學 |
2005 |
Recombinant Candida utilis for the production of biotin.
|
樊琳;Hong, YR;Chen, YL;Yang, WJ;Liao, CH;Shiuan, D |
| 臺北醫學大學 |
2005 |
Deformity of duodenal bulb, gastric metaplasia of duodenal regenerating mucosa and recurrence of duodenal ulcer: A correlated study
|
連吉時; 陳盛煊; 潘憲; 鄭勇山; 張君照; Chang CC; Pan S; Lien GS; Liao CH; Chen SH; Cheng YS |
| 高雄醫學大學 |
2005 |
當歸芍藥散對人血細胞之抗氧化與抗血小板凝集作用
|
沈愛玉;林俊清 ; Shen AY;Wang TS;Huang MH;Liao CH;Chen SJ;Lin CC |
| 高雄醫學大學 |
2005 |
含肟及甲基肟之黃酮與異黃酮衍生物之合成、抗細胞増生及抗血小板凝集活性
|
王泰吉;陳意莉;呂佩融;廖長輝;蕭貴卿;張耿銘;陳義龍;曾誠齊; Wang TC;Chen IL;Lu PJ;Wong CH;Liao CH;Tsiao KC;Chang KM;Chen YL;Tzeng CC |
| 中國醫藥大學 |
2004.10 |
Disabled-2 is a negative regulator of integrin aIIbb3-mediated fibrinogen adhesion and cell signaling.
|
(Huang CL); 鄭如茜(Ju Chien Cheng); (Liao CH); (Stern A); (Hsieh JT); 鄒瑞煌(Ruey-Hwang Chou); (Hsu HL); (Tseng C-P) |
| 國立臺灣大學 |
2004-12 |
Nutritionally variant Streptococcal infections at a university hospital in Taiwan: Disease emergence and high prevalence of -lactam and macrolide resistance.
|
Liao, CH; Teng, LJ; Hsueh, PR; Chen, YC; Huang, LM; Chang, SC; Ho, SW. |
顯示項目 111-120 / 132 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
